Quadralean Thermogenic
Natural health product licensed in Canada
- Licence holder
- RSP Nutrition
- NPN or DIN-HM
- 80077515
- Status
- Inactive licence
- Licence date
- 16 May 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,7-dihydro-1,3,7-triméthyl-1H-purine-2,6-dione Source : Caféine | 66.67 mg | Not calculated |
| Acide linoléique conjugué Source : Acide linoléique conjugué | 166.67 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : N-acétyl L-chlorhydrate de carnitine | 166.67 mg | Not calculated |
| Acide (S)-alpha-amino-4-hydroxybenzènepropanoïque Source : L-Tyrosine | 66.67 mg | Not calculated |
| Capsicum annuum Source : Fruit Extract : Matériel brut sec Extraction ratio : 16:1 Dry plant equivalent : 133.28 mg Potency : 2 % Capsaicinoids | 8.33 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Silice, Stéarate de magnésium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Cayenne is traditionally used in Herbal Medicine to help support peripheral circulation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have CVD, diabetes, metabolic syndrome or insulin resistance.
- Effets indésirables connus
Some people may experience gastrointestinal upset. May cause digestive problems. Hypersensitivity/allergy is known to occur, in which case, discontinue use. Caffeine may cause anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, nervousness, tremor and headache.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are obese or have cardiovascular disease (CVD) risk factors (e.g. high blood pressure, high cholesterol and/or triglycerides). Consult a health care practitioner prior to use if you are of childbearing age, pregnant or breastfeeding. Consult a health care practitioner prior to use if your goal is to achieve weight loss. If you have liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner prior to use if you are following a low protein diet. If symptoms persist or worsen, consult a health care practitioner. If you have stomach ulcers or inflammation, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80077515
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.